PROM1 and colorectal carcinoma: Several studies have shown the increased tumorigenic potential of CD133 positive CRC cells [12,13], its elevated expression being correlated with chemo–radiotherapy resistance [12,14,15], distance metastasis and poor prognosis [16,17].